Arena Pharmaceuticals Inc. (ARNA) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Arena Pharmaceuticals Inc...

    NASDAQ: ARNA · Real-Time Price · USD
    99.99
    0.00 (0.00%)
    At close: Apr 24, 2025, 3:47 PM

    Arena Pharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2021
    Period Ending Dec 31, 2021
    PE Ratio
    		 -8.2
    PEG Ratio
    		 -0.15
    PS Ratio
    		 94.26K
    PB Ratio
    		 7.56
    P/FCF Ratio
    		 -9.73
    P/OCF Ratio
    		 -11.26
    OCF/S Ratio
    		 -8.37K
    Debt / Equity Ratio
    		 0.06
    Quick Ratio
    		 8.59
    Current Ratio
    		 8.59
    Asset Turnover
    		 0.00
    Interest Coverage
    		 -147.22
    Return on Equity
    		 -0.92
    Return on Assets
    		 -0.79
    Return on Invested Capital
    		 -0.85
    Dividend Yield
    		 n/a
    Payout Ratio
    		 n/a
    Gross Profit Margin
    		 1.00
    Net Profit Margin
    		 -11.49K
    Pretax Profit Margin
    		 -11.42K
    Operating Profit Margin
    		 -11.34K
    FCF Margin
    		 -9.69K
    EBITDA Margin
    		 -11.27K

    Add to Watchlist